Mar 11
|
Geron Announces European Commission Approval of RYTELO® (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adults With Transfusion-Dependent Anemia Due to Lower-Risk MDS
|
Mar 11
|
Geron Corporation Announces Departure of Chief Executive Officer
|
Mar 1
|
Analysts Just Shaved Their Geron Corporation (NASDAQ:GERN) Forecasts Dramatically
|
Feb 27
|
We Think Geron (NASDAQ:GERN) Can Afford To Drive Business Growth
|
Feb 27
|
Geron Corp (GERN) Q4 2024 Earnings Call Highlights: Strong Cash Position and Rytelo's FDA ...
|
Feb 27
|
Q4 2024 Geron Corp Earnings Call
|
Feb 26
|
Why Geron Stock Is Plummeting Today
|
Feb 26
|
Geron (GERN) Q4 2024 Earnings Call Transcript
|
Feb 26
|
Geron (GERN) Reports Q4 Loss, Tops Revenue Estimates
|
Feb 26
|
Geron: Q4 Earnings Snapshot
|
Feb 26
|
Geron Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
|
Feb 21
|
Geron to Participate at Upcoming Investor Conferences in March 2025
|
Feb 12
|
Is Geron Corp. (GERN) the Best Nasdaq Stock Under $5 to Buy?
|
Jan 2
|
Why GERN Stock (GERN) is Skyrocketing
|
Jan 1
|
Is Geron Corporation (GERN) the Best Penny Stock to Buy for 2025?
|
Dec 31
|
High Growth Tech Stocks to Watch in December 2024
|
Dec 31
|
Why Is Geron Corporation (GERN) Among the Best Biotech Penny Stocks to Invest in Now?
|
Oct 3
|
Is Geron Corporation (GERN) the Best NASDAQ Stock Under $5?
|
Oct 1
|
High Growth Tech Stocks To Watch This October 2024
|
Sep 30
|
When Can We Expect A Profit From Geron Corporation (NASDAQ:GERN)?
|